Last reviewed · How we verify

NCT03828877

The Effect of Acupuncture on the Treatment of Endovenous Ablation on Pain, IL17 and IL 23

Completed NA Last updated 13 March 2019
What this trial tests

NA trial testing Group A ( Group Acupuncture) in Pain in 70 participants. Completed in 7 March 2019.

Timeline
29 January 2019
Primary endpoint
5 March 2019
7 March 2019

Quick facts

Lead sponsorKahramanmaras Sutcu Imam University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment70
Start date29 January 2019
Primary completion5 March 2019
Estimated completion7 March 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kahramanmaras Sutcu Imam University

Who can join

Adults 18 to 65, any sex, with Pain or Interleukin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acupuncture has emerged in China about 2,000 years ago and is one of the oldest medical procedures in the world. Acupuncture continued to evolve and develop over the centuries, and gradually became one of the standard treatments used in China. Introduced to other regions such as Asia, Europe and the United States. The most extensive use of acupuncture is for pain relief. The aim of this study was to prevent complications due to pain frequently seen in patients who would be treated with endovenous ablation in the postoperative period. In addition, the effect of acupuncture on operative hemodynamics, pain, vascular diameter, postoperative, nausea, vomiting, pain and analgesic needs, IL17 and IL 23.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Kahramanmaras Sutcu Imam University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03828877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing